Amgen Stock Target Price and Analyst Consensus

AMGN Stock  USD 280.07  0.06  0.02%   
The current analyst and expert consensus on Amgen is Buy with 17 hold recommendations. The current projected Amgen target price consensus is 258.80 with 33 analyst opinions. One of the most common ways Amgen Inc analysts use to provide buy-or-sell recommendation to the public are conference calls analysis and financial statements evaluations. Some experts can also talk to Amgen vendors, executives, and/or customers. Amgen recommendation module provides expert sentiment on the projected Amgen Inc target price to derive its highest and lowest estimates based on target price standard deviation of 1.6886.
Lowest Forecast
235.51
Highest Forecast
287.27
Target Price
258.8
As of the 28th of November 2024, Gross Profit is likely to grow to about 20.7 B, while Pretax Profit Margin is likely to drop 0.25. At this time, Amgen's Cash is very stable compared to the past year. As of the 28th of November 2024, Non Current Assets Total is likely to grow to about 70.2 B, while Property Plant And Equipment Net is likely to drop about 3.6 B.
  
It's important to approach Amgen's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize Amgen price targets

Amgen's stock target price is an estimate of its future price, usually made by analysts. Using Amgen's target price to determine if it is a suitable investment can be done through the following steps:
  • Look at Amgen's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Amgen's stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional Amgen Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Amgen is a key component of Amgen valuation and have some predictive power on the future returns of a Amgen.
Hype
Prediction
LowEstimatedHigh
278.91280.59282.27
Details
Intrinsic
Valuation
LowRealHigh
257.95259.63308.08
Details
Naive
Forecast
LowNextHigh
281.68283.37285.05
Details
Earnings
Estimates (0)
LowProjected EPSHigh
4.804.895.08
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Amgen. Your research has to be compared to or analyzed against Amgen's peers to derive any actionable benefits. When done correctly, Amgen's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Amgen Inc.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Macroaxis Index Idea
Macroaxis Index
Invested over 90 shares
Hedge Favorites Idea
Hedge Favorites
Invested over 40 shares
Banking Idea
Banking
Invested over 40 shares
Cash Cows Idea
Cash Cows
Invested few shares
Chemicals Idea
Chemicals
Invested over 30 shares
Impulse Idea
Impulse
Invested over 100 shares
Automobiles and Trucks Idea
Automobiles and Trucks
Invested over 50 shares
Business Services Idea
Business Services
Invested few shares
Blockchain Idea
Blockchain
Invested few shares
ESG Investing Idea
ESG Investing
Invested few shares
FinTech Idea
FinTech
Invested over 40 shares
When determining whether Amgen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Amgen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Amgen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Amgen Inc Stock:
Check out Macroaxis Advice on Amgen to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.